Advertisement

Welcome to the new AJNR, Updated Hall of Fame, and more. Read the full announcements.

AJNR is seeking candidates for the position of Associate Section Editor, AJNR Case Collection. Read the full announcement.

 

Research ArticleBRAIN

Whole Brain Diffusion Tensor Imaging in HIV-Associated Cognitive Impairment

Ann B. Ragin, Pippa Storey, Bruce A. Cohen, Leon G. Epstein and Robert R. Edelman
American Journal of Neuroradiology February 2004, 25 (2) 195-200;

References

  1. ↵
    Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001;410:988–994
    CrossRefPubMedWeb of Science
  2. ↵
    Post MJ, Berger JR, Quencer RM. Asymptomatic and neurologically symptomatic HIV-seropositive individuals: prospective evaluation with cranial MR imaging. Radiology 1991;178:131–139
    PubMedWeb of Science
  3. ↵
    Ernst T, Chang L, Witt M, et al. Progressive multifocal leukoencephalopathy and human immunodeficiency virus-associated white matter lesions in AIDS: magnetization transfer MR imaging. Radiology 1999;210:539–543
    PubMedWeb of Science
  4. ↵
    Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Res B 1996;111:209–219
    CrossRef
  5. ↵
    Eriksson SH, Rugg-Gunn FJ, Symms MR, Barker GJ, Duncan JS. Diffusion tensor imaging in patients with epilepsy and malformations of cortical development. Brain 2001;124:617–626
    Abstract/FREE Full Text
  6. ↵
    Horsfield MA, Larsson HB, Jones DK, Gass A. Diffusion magnetic resonance imaging in multiple sclerosis. J Neurol Neurosurg Psychiatry 1998;64[suppl 1]:S80–S84
  7. ↵
    Marder K. The Dana Consortium on therapy for HIV dementia and related cognitive disorders: clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder. Neurology 1996;47:1247–1253
    Abstract/FREE Full Text
  8. ↵
    Janssen RS, Cornblath DR, Epstein LG, et al. Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus type-1 (HIV-1) infection: report of a working group of the American Academy of Neurology AIDS Task Force. Neurology 1991;41:778–785
    FREE Full Text
  9. ↵
    Price RW, Brew BJ. The AIDS dementia complex. J Infect Dis 1988;158:1079–1083
    Abstract/FREE Full Text
  10. ↵
    Karnofsky DA, Abelman WH, Craver LF, et al. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948;1:634–656
    CrossRefWeb of Science
  11. ↵
    McArthur JC, Grant I. HIV neurocognitive disorders. In: Gendelman JE, Lipton SA, Epstein LS, Swindells S, eds. The Neurology of AIDS. New York: Chapman & Hall;1998
  12. ↵
    Rausch DM, Stover ES. Neuroscience research in AIDS. Prog Neuropsychopharmacol Biol Psychiatry 2001;25:231–257
    CrossRefPubMed
  13. ↵
    Tyler KL, McArthur JC. Through a glass, darkly. Arch Neurol 2002;59:909–912
    CrossRefPubMedWeb of Science
  14. Childs EA, Lyles RH, Selnes OA, et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 1999;52:607–613
    Abstract/FREE Full Text
  15. ↵
    Robertson K, Fiscus S, Kapoor C, et al. CSF, plasma viral load and HIV associated dementia. J Neurovirol 1998;4:90–94
    PubMedWeb of Science
  16. ↵
    Kure K, Llena JF, Lyman WD, et al. Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Hum Pathol 1991;22:700–710
    CrossRefPubMedWeb of Science
  17. ↵
    Ulug AM, Moore DF, Bojko AS, Zimmerman RD. Clinical use of diffusion-tensor imaging for diseases causing neuronal and axonal damage. AJNR Am J Neuroradiol 1999;20:1044–1048
    Abstract/FREE Full Text
  18. ↵
    Tievsky AL, Ptak T, Farkas J. Investigation of apparent diffusion coefficient and diffusion tensor anisotrophy in acute and chronic multiple sclerosis lesions. AJNR Am J Neuroradiol 1999;20:1491–1499
    Abstract/FREE Full Text
  19. ↵
    Filippi CG, Ulug AM, Ryan E, Ferrando SJ, van Gorp W. Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain. AJNR Am J Neuroradiol 2001;22:277–283
    Abstract/FREE Full Text
  20. ↵
    Pomara N, Crandall DT, Choi SJ, Johnson G, Lim KO. White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study. Psychiatry Res 2001;106:15–24
    CrossRefPubMedWeb of Science
  21. ↵
    Tracey I, Hamberg LM, Guimaraes AR, et al. Increased cerebral blood volume in HIV-positive patients detected by functional MRI. Neurology 1998;50:1821–1826
    Abstract/FREE Full Text
  22. ↵
    Nath A, Anderson C, Jones M, et al. Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. J Psychopharmacol 2000;14:222–227
    Abstract/FREE Full Text
  23. ↵
    Bernal F, Saura J, Ojuel J, et al. Differential vulnerability of hippocampus, basal ganglia, and prefrontal cortex to long-term NMDA excitotoxicity. Exp Neurol 2000;161:686–695
    CrossRefPubMed
  24. ↵
    Thompson KA, McArthur JC, Wesselingh SL. Correlation between neurological progression and astrocyte apoptosis in HIV-associated dementia. Ann Neurol 2001;49:745–752
    CrossRefPubMedWeb of Science
  25. ↵
    Gray F, Adle-Biassette H, Chretien F, Lorin de la Grandmaison G, Force G, Keohane C. Neuropathology and neurodegeneration in human immunodeficiency virus infection: pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin Neuropathol 2001;20:146–155
    PubMedWeb of Science
  26. ↵
    Lipton SA, Gendelman HE. Seminars in medicine of the Beth Israel Hospital, Boston: dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 1995;332:934–940
    CrossRefPubMedWeb of Science
  27. ↵
    Bell JE. The neuropathology of adult HIV infection. Rev Neurol 1998;54:816–829
  28. ↵
    Filippi M, Grossman RI. MRI techniques to monitor MS evolution: the present and the future. Neurology 2002;58:1147–1153
    Abstract/FREE Full Text
  29. Power C, Kong P, Crawford TO, et al. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations in the blood-brain barrier. Ann Neurol 1993;34:339–350
    CrossRefPubMedWeb of Science
  30. ↵
    Bencherif B, Rottenberg DA. Neuroimaging of the AIDS dementia complex. Aids 1998;12:233–244
    PubMed
  31. ↵
    Dousset V, Armand J, Huot P, Viaud B, Caille J. Magnetization transfer imaging in AIDS-related diseases. Neuroimaging Clin N Am 1997;7:447–460
    PubMed
  32. Patel SH, Kolson DL, Glosser G, et al. Correlation between percentage of brain parenchymal volume and neurocognitive performance in HIV-infected patients. AJNR Am J Neuroradiol 2002;23:543–549
    Abstract/FREE Full Text
  33. ↵
    Ge Y, Kolson DL, Babb JS, Mannon LJ, Grossman RI. Whole brain imaging of HIV-infected patients: quantitative analysis of magnetization transfer ratio histogram and fractional brain volume. AJNR Am J Neuroradiol 2003;24:82–87
    Abstract/FREE Full Text
  34. ↵
    Tracey I, Carr CA, Guimaeres AR, Worth JL, Navia BA, Gonzalez RG. Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: a proton magnetic spectroscopic study. Neurology 1996;46:783–788
    FREE Full Text
  35. ↵
    Barker PB, Lee RR, McArthur JC. AIDS dementia complex: evaluation with proton MR spectroscopic imaging. Radiology, 1995;195:58–64
    PubMedWeb of Science
  36. ↵
    Chang L, Ernst T, Leonido-Yee M, Walot I, Singer E. Cerebral metabolic abnormalities correlate with clinical severity of HIV-1 cognitive motor complex. Neurology 1999;52:100–108
    Abstract/FREE Full Text
  37. Chang L, Ernst T, Leonido-Yee M, et al. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HID dementia. Neurology 1999;53:782–789
    Abstract/FREE Full Text
  38. Stankoff B, Tourbah A, Suarez S, et al. Clinical and spectroscopic improvement in HIV-associated cognitive impairment. Neurology 2000;56:112–115
  39. ↵
    Sacktor NC, Pomper MG, Horksa A, Barker PB, MacArthur JC. Magnetic resonance spectroscopic imaging measures metabolite changes during therapy for HIV-associated cognitive impairment. Neurology 2000;54:A252
  40. ↵
    Berger JR, Avison MJ. Diffusion tensor imaging in HIV infection: what is it telling us? AJNR Am J Neuroradiol 2001;22:237–238
    FREE Full Text
  41. ↵
    Mukherjee P, McKinstry RC. Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor MR imaging. Radiology 2001;219:756–765
    CrossRefPubMedWeb of Science
  42. ↵
    Cercignani M, Bozzali M, Iannucci G, Comi G, Filippi M. Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2001;70:311–317
    Abstract/FREE Full Text
  43. ↵
    Rocca MA, Cercignani M, Iannucci G, Comi G, Filippi M. Weekly diffusion-weighted imaging of normal-appearing white matter in MS. Neurology 2000;55:882–884
    Abstract/FREE Full Text
  44. ↵
    Werring DJ, Brassat D, Droogan AG, et al. The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study. Brain 2000;123:1667–1676
    Abstract/FREE Full Text
  45. ↵
    Schlaug G, Benfield A, Baird AE, et al. The ischemic penumbra: operationally defined by diffusion perfusion MRI. Neurology 1999;53:1528–1537
    Abstract/FREE Full Text
  46. Hoehn M, Nicolay K, Franke C, van der Sanden B. Application of magnetic resonance to animal models of cerebral ischemia. J Magn Reson Imaging 2001;14:491–509
    CrossRefPubMed
  47. ↵
    Sorensen AG. Apparently, diffusion coefficient value and stroke treatment remains mysterious. AJNR Am J Neuroradiol 2003;23:177–178
  48. ↵
    Kidwell CS, Saver JL, Mattiello, J, et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol 2000;47:462–469
    CrossRefPubMedWeb of Science
  49. ↵
    Ellis RJ, Hsia K, Spector SA, et al. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome: HIV Neurobehavioral Research Center Group. Ann Neurol 1997;42:679–688
    CrossRefPubMedWeb of Science
  50. ↵
    Ho DD, Rota TR, Schooley RT, et al. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 1985;313:1493–1497
    CrossRefPubMedWeb of Science
  51. Davis LE, Hjelle BL, Miller VE, et al. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 1992;42:1736–1739
    Abstract/FREE Full Text
  52. McArthur JC, Cohen BA, Farzedegan H, et al. Cerebrospinal fluid abnormalities in homosexual men with and without neuropsychiatric findings. Ann Neurol 1988;23:S34–S37
  53. ↵
    Spector SA, Hsia K, Pratt D, et al. Virologic markers of human immunodeficiency virus type 1 in cerebrospinal fluid: the HIV Neurobehavioral Research Center Group. J Infect Dis 1993;168:68–74
    Abstract/FREE Full Text
  54. ↵
    McArthur JC, Kieburtz K. Of mice and men: a model of HIV encephalitis. Neurology 2000;54:284–285
    FREE Full Text
Back to top

In this issue

Advertisement
Print
Download PDF
Email Article
Cite this article
0 Responses
Respond to this article
Bookmark this article
Whole Brain Diffusion Tensor Imaging in HIV-Associated Cognitive Impairment
Ann B. Ragin, Pippa Storey, Bruce A. Cohen, Leon G. Epstein, Robert R. Edelman
American Journal of Neuroradiology Feb 2004, 25 (2) 195-200;
del.icio.us logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement